Swedish Orphan Biovitrum appoints president and ceo
Geoffrey McDonough takes the role, joining the firm from Genzyme
McDonough has held several leading positions within Genzyme in the US since 2002, beginning his career with the firm in corporate development.
‘Geoff is well-recognised for his solid and broad commercial and clinical expertise and for his background in the orphan drug and niche speciality market,’ said Bo Jesper Hansen, chairman of Sobi.
‘He will lead Sobi toward our vision of becoming the leading niche speciality pharmaceutical company in Europe.’
You may also like
Pharmaceutical
Optimising process steps and performance with agitated Nutsche filter-dryers
Agitated Nutsche filter dryers (ANFD) streamline solid-liquid separation by performing filtration, dewatering, and drying in a single sealed vessel; an enormous boon in fine chemicals and pharmaceutical production
Sustainability
ACG Packaging Materials becomes first pharma packaging firm to join WEF Lighthouse Network
The company has joined the World Economic Forum’s Global Lighthouse Network after its Shirwal facility was named a Lighthouse site, making it the world’s first pharmaceutical packaging company to receive the recognition for smart, sustainable manufacturing
Pharmaceutical
testo Saveris 1 update automates environmental monitoring workflows for pharma compliance
New features include automated workflows for efficient environmental monitoring, approvals for secure and compliant changes, and more flexible control of webhooks, as well as further improvements in performance, transparency and usability